Analysis Report : Global Aromatherapy Market 2020 | Demand and Size share Research report

 Market Scenario

Market Research Future (MRFR) postulates that the aromatherapy market is estimated to garner USD 4.3 billion, grabbing a healthy CAGR of 6.18 % during the forecast period (2017-2023). The non-invasive nature of aromatherapy is encouraging the market growth. Aromatherapy is practiced across the globe to treat several conditions like burns, eczema, acne, skin rashes, etc. and is also being gradually approved for pain management. Aromatherapy is common among the geriatric population as they help to heal chronic pain. The procedure is progressively being used at homes for instant relief from cold and flu, relaxation and sleep, mood enhancement, and pain relief. They are cost-effective, offer privacy and convenience. Aromatherapy finds application in the skin and hair care, relaxation, cold and cough, pain management, scar management, insomnia, and others.

Market Potential and Pitfalls

The aromatherapy market is experiencing an up thrust across the globe with a large number of the global population opting for aromatherapy, non-invasive nature of aromatherapy, and increasing lifestyle industry. The modern lifestyle is encircled with problems such as stress and sleep disturbances which have further inflated the market growth. Aromatherapy used aromatic and other essential oils which helps to combat cold, increase immunity and improve breathing disorders. Such benefits have encouraged the aromatherapy market worldwide. The surging practice of aromatherapy at home, growing customer fondness towards the use of natural products, and the high prevalence of lifestyle diseases are likely to propel the market growth in the coming years.

Essential oils used in aromatherapy possess several natural healing factors. Therapeutic grade essential oils have a positive impact on the overall wellness of the patient. They are considered a natural cleanser and also an antibacterial remedy when ingested. Moreover, people across the globe are becoming aware of the benefits provided by such natural therapies, which is further encouraging the market growth. Consumers are buying cosmetic products integrated with aromatherapy ingredients and essential oils. Aromatherapy products including and creams, bath salts, and massage oils are popular among the consumers. Manufacturers are thus offering a varied range of aromatherapy consumables which consist of natural ingredients, pleasant smell, and relaxing properties. Oils such as lavender, lemongrass, and peppermint are gaining huge prominence among the manufactures. Such factors are influencing the growth of the aromatherapy market across the globe.

On the contrary, the toxic nature of the essential oils and a dearth of proper guidelines are considered some of the top barriers vitiating the market growth across the globe. For instance, Cineole is an essential oil which can be poisonous above the recommended dose. An overdose can cause nausea, epigastric burning, dizziness, vomiting, rapid heartbeat, muscular weakness, feeling of suffocation, etc.

Global Aromatherapy Market: Segmental Analysis

The global aromatherapy market has been segmented on the basis of product, application, and therapeutic application.

By mode of product, the global aromatherapy market has been segmented into essential oils and equipment. Among these, the essential oils segment is likely to gain prominence in the coming years owing to the increased awareness regarding the therapeutic value of these oils.

By mode of application, the global aromatherapy market has been segmented into inhalation, tropical, and aerial diffusion.

By mode of therapeutic application, the global aromatherapy market has been segmented into relaxation and sleep, skin and hair care, pain management, and other remedies. Among these, the relaxation & sleep segment is considered to gain prominence in the coming years owing to the surging number of people suffering from stress and anxiety along with the side effects associated with alternative medicines.

Regional Insights

Geographically, the aromatherapy market span across regions namely, Europe, North America, Asia Pacific, and the Middle East & Africa.

Considering the global scenario, the North American region is the most prominent region in the global market with the U.S. generating the maximum revenue. The high per capita income and high population density are the top two factors encouraging the market growth in this region. The surging awareness among the people regarding the health benefits of essential oils and aromatherapy coupled with the rising demand for herbal products for personal care are contributing to the growth of the market.

The European region is estimated to occupy the second spot and is likely to expand at the fastest speed. France is considered the largest market in this region owing to the tradition of aromatics. The presence of prominent market players has further influenced the market growth.

The Asia Pacific region is experiencing steady growth with China being the largest market owing to the presence of a large population. The region has proved to be a potential region for the market players owing to the surging incidences of lifestyle and chronic diseases, high population base, and growing disposable income of the people. Medical tourism makes the region a lucrative region for aromatherapy as economies like India having the traditional process of using natural resources and essential oils for treating various illness attract tourists across the globe.

Industry Updates

March 27, 2019: Lunaroma Aromatic Apothecary in Burlington offer over hundreds of essential oils and they are now making their way into modern medicine with doctors using the age-old technique to help their patients.

Competitive Dashboard

The prominent players operating the global aromatherapy market comprises NOW Foods, Muji, Tree of Life, Young Living, Neal’s Yard Remedies, dōTERRA, Zija International, Nu Skin, Air Aroma, and others.

Read more @ https://www.marketresearchfuture.com/reports/aromatherapy-market-3241

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:                                    

Akash Anand                                                                        

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

 

Diagnostic Electrocardiograph (ECG) Market Trends 2020 - Analysis |Size |share and Demand

 Diagnostic Electrocardiograph (ECG) Market Overview

Electrocardiograph is a device used to observe the heart's activity and helps in gaining accurate details about the same. As the global population increases, heart diseases are also increasing, which has provided lucrative growth. Also, it is a minimally invasive technique that makes it considerable between the patients and doctors. In this fast-moving world, people are unable to take good care of themselves and adopt unhealthy lifestyle habits, which are among the major forces responsible for the increase in heart-related diseases.

Get a FREE Sample Report @ https://www.marketresearchfuture.com/sample_request/8787

This has created huge demands for diagnostic electrocardiographs, as it is also capable of producing accurate results. As the population and patient count increase, the authorities are now increasing the healthcare budgets and are improving their healthcare facilities, which has provided the necessary boost to this market. With the increase in demands and applications, the companies are investing in research & development programs to improve the system's efficiency, which will help the market gain momentum. 

Apart from the uses and features, the global diagnostic electrocardiograph market is facing friction from factors like scarcity of trained professionals and struggling economic structures, which has slowed down the market's growth. This report provides a comprehensive outlook on competition, opportunities, drivers & restraints, and other factors affecting the local and global diagnostic electrocardiograph (ECG) market. The global market is anticipated to register approximately a 06 % annual growth during this period.

Diagnostic Electrocardiograph (ECG) Market Division

The global diagnostic electrocardiograph (ECG) market is segmented into classes as follows:

The global diagnostic electrocardiograph market is segmented into stress ECG devices, smart ECG monitors, rest ECG devices, and others based on product types.

The global diagnostic electrocardiograph market divided into the single lead, 3 lead, 5 lead, and other devices based on lead type.

Based on end-users, the global diagnostic electrocardiograph market is segmented into hospitals, clinics, and others.

Diagnostic Electrocardiograph (ECG) Market Regional Classification

The diagnostic electrocardiograph (ECG) market has gained global adoption due to its rising patient counts, demands for better equipment, and a rise in healthcare standards. The Asia Pacific, North America, Europe, and the rest of the world are the major market studies for the global diagnostic electrocardiograph market. The North American region is leading the market due to the presence of key manufacturers, demands for advanced technologies, increasing research & development activities, a well-established healthcare system, rigid regulations, and other factors. The Asia Pacific region will register the fastest growth rates due to the vast population covers, rapid urbanization, fast-developing healthcare systems, increasing health issues, and other factors with India and China among the market leaders due to rapid development and presence of vast opportunities.

Industry News

The global diagnostic electrocardiograph market is a necessary part of the healthcare system. The growing awareness and increase in patient numbers have provided essential growth to this market. Resting ECG devices and 3 lead ECG devices will lead the market throughout the tenure. The global market is led by The North American region, whereas the Asia Pacific region will file the fastest growth in this period.

Key Players

• General Electric Company (US)
• Koninklijke Philips N.V. (Netherlands)
• Nihon Kohden Corporation (Japan)
• Hillrom Services, Inc. (US)
• Spacelabs Healthcare (US)
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China)
• Schiller (Switzerland)
• ACS Diagnostics (US)
• BPL Medical Technologies (India)
• Fukuda Denshi (Japan)
• BTL (US)
• Edan Instruments, Inc. (China)
• Cardioline SpA (Italy)
• Norav Medical (US)
• Innomed Medical Inc. (Hungary)
• VectraCor, Inc. (US)

 

Browse Complete 90 Pages Premium Research Report Enabled with 30+ Respective Tables and Figures at  https://www.marketresearchfuture.com/reports/diagnostic-electrocardiograph-market-8787

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:                                    

Akash Anand                                                                        

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

What are the main top Leaders of Global Cystic Fibrosis Market ?

 The global market consist of players such as AbbVie, Allergan plc, Chiesi Farmaceutici S.p.A., F. Hoffmann-La Roche AG, Gilead Sciences, Inc., Novartis AG, Pharmaxis Ltd, PTC Therapeutics, and Vertex Pharmaceuticals Incorporated are some of the prominent players at the forefront of competition in the global cystic fibrosis market and are profiled in MRFR Analysis report.

Global Cystic Fibrosis Market - Overview:

According to a recent study report published by the Market Research Future analysts, the global cystic fibrosis therapeutics market is growing at a double digit CAGR. The major growth in the cystic fibrosis market was observed with the introduction of Kalydeco drug by Vertex pharmaceutical in 2012. There has been constant development of new drugs and therapies for treating cystic fibrosis. Cystic fibrosis foundation (CFF) has always been in support of the companies involved in the research and development of the cystic fibrosis drugs. The financial support from CFF is influential in the growth of the cystic fibrosis market worldwide.

That being said, there are few hurdles as well in growth of this market. Currently there are approximately 1900 identified CFTR mutations that are responsible for the development of the disease condition. Many are yet to be identified. At present, treatments are available for nearly half the mutations. CF being the rare disease, and due to the limited information available, the extensive research is required. The research and development cost for the cystic fibrosis is very high leading to the massive prices of the end products. High cost of the drugs and treatments is one of the factors that hinder the growth of the cystic fibrosis market.

Global Cystic Fibrosis Market - Competitive Analysis:

The global market for cystic fibrosis is dominated by American pharmaceutical company Vertex Pharmaceuticals Incorporated.  With two FDA approved CFTR modulator drugs Kalydeco & Orkambi, Vertex Pharmaceuticals secured a top spot with the market share of 46% in the global cystic fibrosis market. Kalydeco and Orkambi are the drugs that affect the disease at a genetic level where as all the other drugs from different companies deal with the disease symptoms and associated problems. Currently there is no competition for the Kalydeco and Orkambi. Moreover the Vertex is on the verge of developing their next and better drug “triple combo” which is expected to cover 90% of the total identified CFTR mutations. This development is the strong reason for Vertex pharmaceutical to be on top of the table in the near future as well.

Apart from the Vertex, there are some companies which are manufacturing different drugs for the treatment for the cystic fibrosis. These companies have drug products such as Roche- Pulmozyme, Abbvie- Creon, Gilead- Cayston, Novartis- TOBI Podhaler, Allergan- Zenpep, Chiesi- Pertzye, and few others. As these products help patients in managing the cystic fibrosis symptoms and are consumed daily, these companies have fair amount of share in the market. Additionally, there are other companies which such as Pharmaxis, PTC therapeutics, Janssen Pharmaceuticals, Inc which are involved in the development of the treatments for the symptoms of cystic fibrosis.

Global Cystic Fibrosis Market - Regional Analysis;

Cystic fibrosis can occur in both genders as well as in all ethnic groups and races. However the incidences of cystic fibrosis varies across the globe. Cystic fibrosis is more common among the Caucasians. Hence the disease is more prevalent in North America, Europe, and Australia. However cystic fibrosis can also affect Latinos, American Indians, African, and Middle Eastern population.

North America is one of the majorly affected region by the deadly disease cystic fibrosis. The United States is among the countries with highest incidence rates of cystic fibrosis. According to cystic fibrosis foundation, more than 30,000 patients are living with cystic fibrosis in the United States. Nearly, 1000 new cystic fibrosis cases are diagnosed each year. According to CFF’s national patient registry, the median age of the person with cystic fibrosis is currently 33.4 years. The average life expectancy of the CF patients has increased significantly as compared to the patients 30 years back.

European region is also largely affected by cystic fibrosis. According to European Cystic Fibrosis Society (ECFS), considering the 26 major countries in Europe, more than 35,500 people were suffering from cystic fibrosis in 2014. Among the CF patients in Europe, 51.8% were adults with age 18 years or more and 48.2% were less than 18 years old. Countries like United Kingdom, Ireland, Romania, and Bulgaria have the high birth prevalence of CF.

The prevalence of cystic fibrosis is seen to be very low in the Asian region. There is limited information available about CF in Asia, it is likely that the disease is highly underdiagnosed in this region including the Indian subcontinent. It is due to medical community’s lack of knowledge about CF and poor access to the medical and healthcare facilities for cystic fibrosis patients.

The incidence of cystic fibrosis in Middle East varies according to the ethnic background. However, the CF prevalence in Middle East is low as compared to the North American and European region. There are no accurate CF prevalence number for the Northern African countries, but it is expected to be low due to the racial factor and no European genetic mixture.

Access Complete Report @ https://www.marketresearchfuture.com/reports/cystic-fibrosis-market-1825

2022 Available At Market Research Future

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

 

Global Covid19/CoronaVirus Impact on Cystic Fibrosis (CF) Therapeutics Market Growing at a CAGR of 13.5% By Market Growth, Trends, Absolute Opportunity and Value Chain 2018 to 2025

The global market consist of players such as AbbVie, Allergan plc, Chiesi Farmaceutici S.p.A., F. Hoffmann-La Roche AG, Gilead Sciences, Inc., Novartis AG, Pharmaxis Ltd, PTC Therapeutics, and Vertex Pharmaceuticals Incorporated are some of the prominent players at the forefront of competition in the global cystic fibrosis market and are profiled in MRFR Analysis report.

Global Cystic Fibrosis Market - Overview:

According to a recent study report published by the Market Research Future analysts, the global cystic fibrosis therapeutics market is growing at a double digit CAGR. The major growth in the cystic fibrosis market was observed with the introduction of Kalydeco drug by Vertex pharmaceutical in 2012. There has been constant development of new drugs and therapies for treating cystic fibrosis. Cystic fibrosis foundation (CFF) has always been in support of the companies involved in the research and development of the cystic fibrosis drugs. The financial support from CFF is influential in the growth of the cystic fibrosis market worldwide.

That being said, there are few hurdles as well in growth of this market. Currently there are approximately 1900 identified CFTR mutations that are responsible for the development of the disease condition. Many are yet to be identified. At present, treatments are available for nearly half the mutations. CF being the rare disease, and due to the limited information available, the extensive research is required. The research and development cost for the cystic fibrosis is very high leading to the massive prices of the end products. High cost of the drugs and treatments is one of the factors that hinder the growth of the cystic fibrosis market.

Global Cystic Fibrosis Market - Competitive Analysis:

The global market for cystic fibrosis is dominated by American pharmaceutical company Vertex Pharmaceuticals Incorporated.  With two FDA approved CFTR modulator drugs Kalydeco & Orkambi, Vertex Pharmaceuticals secured a top spot with the market share of 46% in the global cystic fibrosis market. Kalydeco and Orkambi are the drugs that affect the disease at a genetic level where as all the other drugs from different companies deal with the disease symptoms and associated problems. Currently there is no competition for the Kalydeco and Orkambi. Moreover the Vertex is on the verge of developing their next and better drug “triple combo” which is expected to cover 90% of the total identified CFTR mutations. This development is the strong reason for Vertex pharmaceutical to be on top of the table in the near future as well.

Apart from the Vertex, there are some companies which are manufacturing different drugs for the treatment for the cystic fibrosis. These companies have drug products such as Roche- Pulmozyme, Abbvie- Creon, Gilead- Cayston, Novartis- TOBI Podhaler, Allergan- Zenpep, Chiesi- Pertzye, and few others. As these products help patients in managing the cystic fibrosis symptoms and are consumed daily, these companies have fair amount of share in the market. Additionally, there are other companies which such as Pharmaxis, PTC therapeutics, Janssen Pharmaceuticals, Inc which are involved in the development of the treatments for the symptoms of cystic fibrosis.

Global Cystic Fibrosis Market - Regional Analysis;

Cystic fibrosis can occur in both genders as well as in all ethnic groups and races. However the incidences of cystic fibrosis varies across the globe. Cystic fibrosis is more common among the Caucasians. Hence the disease is more prevalent in North America, Europe, and Australia. However cystic fibrosis can also affect Latinos, American Indians, African, and Middle Eastern population.

North America is one of the majorly affected region by the deadly disease cystic fibrosis. The United States is among the countries with highest incidence rates of cystic fibrosis. According to cystic fibrosis foundation, more than 30,000 patients are living with cystic fibrosis in the United States. Nearly, 1000 new cystic fibrosis cases are diagnosed each year. According to CFF’s national patient registry, the median age of the person with cystic fibrosis is currently 33.4 years. The average life expectancy of the CF patients has increased significantly as compared to the patients 30 years back.

European region is also largely affected by cystic fibrosis. According to European Cystic Fibrosis Society (ECFS), considering the 26 major countries in Europe, more than 35,500 people were suffering from cystic fibrosis in 2014. Among the CF patients in Europe, 51.8% were adults with age 18 years or more and 48.2% were less than 18 years old. Countries like United Kingdom, Ireland, Romania, and Bulgaria have the high birth prevalence of CF.

The prevalence of cystic fibrosis is seen to be very low in the Asian region. There is limited information available about CF in Asia, it is likely that the disease is highly underdiagnosed in this region including the Indian subcontinent. It is due to medical community’s lack of knowledge about CF and poor access to the medical and healthcare facilities for cystic fibrosis patients.

The incidence of cystic fibrosis in Middle East varies according to the ethnic background. However, the CF prevalence in Middle East is low as compared to the North American and European region. There are no accurate CF prevalence number for the Northern African countries, but it is expected to be low due to the racial factor and no European genetic mixture.

Access Complete Report @ https://www.marketresearchfuture.com/reports/cystic-fibrosis-market-1825

2022 Available At Market Research Future

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

 

Covid19/CoronaVirus Impact on Custom Antibody Market reaching the value of USD 1,106.76 million with CAGR 9.6% by 2023

 

Market Highlights:

The Global Custom Antibody Market is expected to register a growth of significant CAGR 9.6% during the forecast period (2018–2023). The custom antibody provides high specificity and selectivity, these are easy to produce as compared to other antibodies and are hence the preferred choice in all types of research studies. Rising geriatric population, growing R&D investment and number of drugs in the pipeline are further anticipated to fuel the market growth. Growth in this segment is mostly driven by the need for high-quality antibodies for research reproducibility and producing high-quality therapeutics.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/7062

Segmentation:

The Global Custom Antibody Market has been segmented on the basis of service, source, type, research area and end users.On the basis of service, the market has been classified as antibody development, antibody production & purification, antibody fragmentation & labeling. The antibody development is segmented in to antibody characterization, antigen preparation, immunization & hybridoma production. On the basis of source, the market has been classified as mice, rabbits, human beings and others. On the basis of type, the market has been classified as monoclonal antibodies, polyclonal antibodies, recombinant antibodies, others. On the basis of research area, the market has been classified as oncology, infectious diseases, immunology, neurobiology, stem cells, cardiovascular diseases, other research areas. On the basis of end users, the market has been classified as pharmaceutical & biotechnology companies, hospitals and clinics, academic & research institutes, contract research organizations.

Regional Analysis:

The Americas is projected to lead the custom antibody market in the forecast period. Increasing healthcare awareness, advancement in technology, medical tourism are some other factors that boost the growth of the market. Also, growing investments in the progress of structure-based drug designs, growing focus on developing antibody-based therapeutics, rising research in the fields of genomics field, increasing demand for good quality research tools for data reproducibility and the existence of a huge number of global players in this region.

The European market is expected to hold the second largest market share. The market is expected to witness growth owing to the rising patient population, changing lifestyle, and growing elderly population. This is expected to provide favorable backgrounds for the market to grow. According to the Parkinson’s news today, the frequency of Parkinson’s disease in the U.K. is about 1 in 500 people, with a total of about 127,000 people living with the disease. According to Capra Science, a European company specialized in custom antibody production, llama-derived nanobodies might find therapeutic application in Parkinson’s disease.

Asia-Pacific is projected to be the fastest growing region for the global custom antibody in 2018. It is expected to witness profitable growth over the forecast period due to the existence of favorable healthcare schemes drafted by government agencies and growing research activities in the field of mAb-based therapeutics. Awareness programs and quality assurance of diagnostic procedures have added importance in the developing economies of Korea, Taiwan, China, Sri Lanka and India since the last few years.

The Middle East and Africa accounts for the least share due to stringent government policies and low per capita income.

Key Players:

Some of the key players in the global custom antibody market are Thermo Fisher Scientific Inc., Genscript, Abcam PLC, Merck Group, Bio-Rad Laboratories, Inc., Cell Signaling Technology, Inc., Agilent Technologies, Inc., Biolegend, Inc., Rockland Immunochemicals Inc., Promab Biotechnologies, Inc., Proteogenix, Innovagen Ab.

Browse Complete Report @ https://www.marketresearchfuture.com/reports/custom-antibody-market-7062

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

 

LAtest Updates: Spirometry Market Size, share, Report, Growth by 2023

 Spirometry Market Overview:

The global spirometry market is expecting to touch a valuation of USD 1,106.46 million by 2023, according to Market Research Future (MRFR).  The high prevalence of respiratory disorders is the major factor driving the market growth from 2018 to 2023 (forecast period). Rising cases of chronic obstructive pulmonary disorders (COPD), technological advances in respiratory care devices, and the expanding geriatric population are factors expected to spur market demand till 2023. As per a report by Asthma UK in 2016, nearly 1,410 people died from asthma.

Get Request Free Sampl @ https://www.marketresearchfuture.com/sample_request/6539

Government initiatives to curtail smoking habits, focus on breathing diseases, rising levels of air pollution, and adoption of spirometers at homes are factors likely to augur market growth. Awareness of reimbursement policies among the public and clinicians are projected to drive patients towards taking these tests. But high costs of spirometers can act as a deterrent against market growth.

Spirometry Market Segmentation:

The spirometry market can be segmented by product, technology, application, and end-user.

By product, the market is segmented into table-top spirometry, hand-held spirometry, and desktop (PC) spirometry. The table-top spirometry segment accounted for 49.9% market share in 2017, followed by hand-held (31%), and desktop (19.1%). This can be attributed to adoption of spirometers in hospitals and clinics. But the desktop segment is touted to register the highest CAGR of 10.58% during the forecast period owing to its rapid diagnosis rate and increasing use of computer-based applications.

By technology, the market covers flow measurement spirometry, volume spirometry, and peak flow meters (PFM). The flow measurement spirometry segment accounted for 50.3% share in 2017. This can be attributed to its lightweight nature and compact size. Its functionality based on the familiar table-top spirometer technology and lack of frequent calibration make it popular among clinicians. But the PFM technology can register 10.58% CAGR over the forecast period to reach USD 149.76 million by 2023.

Major applications of the spirometry market include diagnostic and treatment monitoring. The diagnostic segment is further sub-segmented into asthma, interstitial pulmonary fibrosis, and COPD. The diagnostic segment accounted for 68.93% share of the market in 2017, spurred by the prevalence of breathing diseases such as asthma. But the treatment monitoring segment can exhibit the highest CAGR during the review period to reach a valuation of USD 353 million by 2023. Its valuation in 2018 was suggested to be USD 214.12 million.

Key market end-users include hospitals & clinics, research & academic institutes, diagnostic centers, and home care. The home care segment is projected to enjoy a 9.90% CAGR to reach a valuation of USD 71.14 million by 2023 from USD 44.38 million in 2018.

Spirometry Market Regional Analysis:

The spirometry market covers the latest trends and opportunities across Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).

The Americas accounted for 39.74% share in the global market in 2017, followed by Europe and APAC. This can be attributed to economies such as the U.S. which are the earliest adopters of latest technologies coupled with the large patient pool suffering from respiratory disorders. The region is likely to enjoy a 10.25% CAGR over the forecast period.

The Europe spirometry market is expected to enjoy a CAGR similar to the Americas market over the forecast period to touch a valuation of USD 322.33 million by 2023. This can be credited to rising number of asthma cases and ballooned healthcare expenditure of nations such as Germany and France.

The MEA region can experience a respectable CAGR during the review period owing to improvements of healthcare infrastructure and enhanced healthcare budgets of Kuwait, Qatar, and Dubai.

The APAC region is expected to exhibit a 10.94% CAGR over the forecast period owing to high cases of chronic diseases, awareness of respiratory devices, and increased healthcare budgets of developed nations in the region. The growing geriatric populace in China and Japan can contribute to regional market revenue till 2023.

Spirometry MarketCompetitive Dashboard:

Key players in the spirometry market include Smiths Medical Inc. (U.S.), Vitalograph (U.K.), MGC Diagnostics Corporation (U.S.), Hill-Rom Holdings, Inc. (U.S.), Schiller AG (Switzerland), COSMED srl (Italy), Midmark Corporation (U.S.), NDD Medical Technologies, Inc. (U.S.), Carefusion Corporation (U.S.), Nihon Kohden Corporation (Germany), and Koninklijke Philips N.V. (The Netherlands).

Access Report @ https://www.marketresearchfuture.com/reports/spirometry-market-6539

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

 Contact:

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com